A shot in the arm: Moderna’s co-founder on the COVID-19 vaccine

A Shot In The Arm: The COVID-19 Vaccine Arrives | Moderna Co-Founder Noubar Afeyan | GZERO World

The pandemic's US death toll shows no signs of abating and the holiday season's spike will likely dwarf any surge that came before it. But in the midst of this dark winter there are glimmers of hope, as the first of the COVID-19 vaccines have nearly arrived (or, depending on when you read this, already have). On GZERO World, Ian Bremmer interviews Noubar Afeyan, the co-founder of a leading vaccine developer Moderna. They'll discuss distribution plans, the revolutionary science behind Moderna's vaccine, and how a company younger than Twitter became a frontrunner in the race to end the pandemic.

More from GZERO Media

Earlier this month, Microsoft released the 2025 TechSpark Impact Report, which highlights how the company is assisting regions across the US in achieving these goals. Since its launch, TechSpark has obtained over $700 million in community funding, supported more than 65,000 people in developing digital skills, and, thanks to the work of TechSpark Fellows, catalyzed $249M+ in funding and upskilled 34,600 individuals across 46 communities — highlighting the ripple effect of local leadership and innovation. Learn more about this progress in the 2025 report here.

People walk past a jewelry store in the Diamond District of Manhattan, New York City, USA, on August 6, 2025.
Jimin Kim / SOPA Images via Reuters Connect

GZERO spoke to Eurasia Group’s Commodities Director Tim Puko to better understand why the diamond industry has tanked, and the consequences of this for geopolitics.

- YouTube

In Ask Ian, Ian Bremmer notes that US–China relations are once again on edge. After Washington expanded export controls on Chinese tech firms, Beijing struck back with new limits on critical minerals. President Trump responded by threatening 100% tariffs, then quickly walked them back.

In this episode of The Ripple Effect: Investing in Life Sciences, host Dan Riskin speaks with Patrick Horber, President of Novartis International, and David Gluckman, Vice Chairman of Investment Banking and Global Head of Healthcare at Lazard. Together, they break down the outsized economic impact of life science innovation, from trillions in US bioscience output to China’s meteoric rise as a global R&D hub.

RPG-7 training of Ukrainian soldiers. November 17, 2024.
  • Adrien Vautier via Reuters Connect

People from different cultures often approach the same problem in different ways. We wondered — would an AI trained and tuned in China approach a complex geopolitical challenge differently than a model created and trained in Europe, or in the United States?

French President Emmanuel Macron speaks to the members of the media, after arriving by plane to attend the Gaza Peace Summit, in Sharm el-Sheikh, Egypt, October 13, 2025.
Yoan Valat/Pool via REUTERS

2: French President Emmanuel Macron rejected calls to resign as his fragile government faces two no-confidence votes this week.